[1]
Sicras-Mainar, A. and Navarro-Artieda, R. 2014. Combination therapy of metformin vs dipeptidulpeptidase inhibitors and sulfonylureas in type 2 diabetes: clinical and economic impact. Revista Peruana de Medicina Experimental y Salud Pública. 31, 4 (Dec. 2014). DOI:https://doi.org/10.17843/rpmesp.2014.314.111.